Related Experiment Videos

A novel conus peptide ligand for K+ channels

Michael Ferber1, Annett Sporning, Gunnar Jeserich

  • 1AG Molekulare und Zelluläre Neuropharmakologie, Max-Planck-Institut für Experimentelle Medizin, Hermann-Rein-Str. 3, D-37075 Göttingen, Germany.

Summary

A novel Conus peptide, kappaM-conotoxin RIIIK, specifically blocks Shaker K(+) channels, not sodium channels. It interacts with the Shaker K(+) channel pore region, offering new insights into potassium channel modulation.

Related Concept Videos